Glaucus Research Shorts AAMC, Goes Long RESI

Glaucus Research Group California LLC is Short Altisource Asset Management Corp (NYSE:AAMC) and Long Altisource Residential Corp (NYSE:RESI) 

video parody of this Investment Research Report can be viewed here.



Q2 Hedge Funds Portable Database Now LIVE!!! Letters, Conferences, Slides And More [UPDATED 7/13 14:48 EST]

Q2 Hedge Funds Resource PageSimply click the menu below to perform sorting functions. This page was just created on 7/1/2020 we will be updating it on a very frequent basis over the next three months (usually at LEAST daily), please come back or bookmark the page. As always we REALLY really appreciate legal letters and tips on hedge funds Read More

ALTISOURCE ASSET MANAGEMENT CORP (NYSE: AAMC) (“AAMC”), a recent spinoff from Bill Erbey’s empire of distressed real estate and mortgage interests, is the asset manager for ALTISOURCE RESIDENTIAL CORP (NYSE:RESI) (“RESI”), which owns a portfolio of non-performing mortgages (“NPLs”) and foreclosed single-family homes. We believe that AAMC’s asset management fee is at least four to seven times higher than the compensation received by similarly situated asset managers, and as such, is a sweetheart deal that will unjustly enrich insiders with a beneficial stake in AAMC at the expense of RESI’s shareholders.

As shareholders of RESI, we believe that RESI’s independent directors have a fiduciary duty to either terminate or substantially renegotiate its asset management agreement with AAMC. We expect to sue RESI’s independent directors for violating their fiduciary duty of loyalty to RESI’s shareholders unless they address the lopsided compensation deal given to AAMC.

The market believes that the NPV of AAMC’s Incentive Fee is a staggering $2.7 billion. We project that RESI’s share price will increase by 114% and its dividends will increase by $0.15 per quarter per share if it captures ¾ of these expected cash flows. We also estimate that AAMC’s share price will fall by up to 87% as its compensation is brought in line with market rates.


Short Aamc-glaucusresearch-long Resi-mar 19 2014